Clinical Trials
3 trialsNCT04542382 2025-03-30
BCRPmarker
University of California, San Francisco
Phase 1 Completed
NCT05924152 2024-03-13
A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib
Mirati Therapeutics Inc.
Phase 1 Completed
NCT00358540 2017-11-13
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
GlaxoSmithKline
Phase 1 Completed